Mainz Biomed B.V. (MYNZ): Price and Financial Metrics
MYNZ Price/Volume Stats
| Current price | $1.99 | 52-week high | $28.00 |
| Prev. close | $2.04 | 52-week low | $1.92 |
| Day low | $1.97 | Volume | 59,791 |
| Day high | $2.09 | Avg. volume | 198,548 |
| 50-day MA | $2.67 | Dividend yield | N/A |
| 200-day MA | $6.58 | Market Cap | 6.85M |
MYNZ Stock Price Chart Interactive Chart >
Mainz Biomed B.V. (MYNZ) Company Bio
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
MYNZ Price Returns
| 1-mo | -19.43% |
| 3-mo | -54.41% |
| 6-mo | -62.87% |
| 1-year | -92.79% |
| 3-year | -99.47% |
| 5-year | N/A |
| YTD | -53.94% |
| 2024 | -90.69% |
| 2023 | -83.66% |
| 2022 | -31.67% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...